Tacrolimus immediate-release formulations are authorised for use in preventing organ rejection in adult and paediatric patients undergoing allogeneic liver, kidney, heart, or lung transplants when used in combination with other immunosuppressant. When paired with other immunosuppressant, tacrolimus extended-release formulations are approved for the prevention of organ rejection in adult and...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian